Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

NCT02475447

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +13 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Axis Clinical Research Los Angeles, California, United States
  • Tory Sullivan, MD PA North Miami Beach, Florida, United States
View all 22 locations
View Trial Details
Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

NCT02564055

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • GSK Investigational Site Fort Smith, Arkansas, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Irvine, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT02260986

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Phoenix, Arizona, United States
  • Hot Springs, Arkansas, United States
  • Little Rock, Arkansas, United States
  • Encinitas, California, United States
View all 148 locations
View Trial Details
Completed

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

NCT01639040

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Berlin, Germany
  • Dresden, Germany
  • Dülmen, Germany
  • Frankfurt, Germany
View all 13 locations
View Trial Details
Completed

First in Human of Single and Multiple Doses of MOR106

NCT02739009

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • SGS LSS Clinical Pharmacology Unit Antwerp, Belgium
  • St Johns Hospital Budapest, Hungary
  • • Arensia Phase I unit Chisinau, Moldova
  • Arensia Phase I unit Bucharest, Romania
View Trial Details

Related conditions